Stay Updated with the Latest BGC Partners, Inc. BGCP News in Real Time
Find BGCP news now at Meyka AI. Stay informed with the latest BGC Partners, Inc. stocks updates, including price news, market analysis, and expert insights.
Indiana Ends Ambulance Diversion Policy Starting September 1, 2026
Indiana hospitals can no longer divert ambulances due to overcrowding starting September 1, 2026. The state joins Massachusetts and Rhode Island in ending the 25-year practice that delayed critical care.
Two Singapore Wealth Gurus Declared Bankrupt; S$5M Investor Funds at Risk
Lim Jian Bin and Jason Fong Wai Hong, who promised guaranteed 15% returns, declared bankrupt in July and April 2026. Over 50 investors have S$5 million tied up in their schemes. Police investigating.
Partners Group Stock Drops 9.7% as H1 Profit Falls 13%, CEO to Step Down
Partners Group stock plunges 9.7% after H1 profit fell 13% to CHF 502 million. CEO David Layton to return to investment role; co-CEO structure returns January 2027.
Connor Hellebuyck Requests Trade From Jets as Vezina Winner Seeks New Home
Connor Hellebuyck, three-time Vezina Trophy winner, publicly confirms trade request from Winnipeg Jets. The 33-year-old goaltender seeks new team before NHL training camp in September.
US Ends Military Aid to Iraqi Kurds by September 30, 2026
Pentagon halts military aid to Kurdish Peshmerga forces as four-year security agreement expires September 30, 2026. Kurds fear power vacuum and Iranian expansion.
Autodesk (ADSK) Stock Falls 4% Despite Q2 Earnings Beat as Fiscal 2027 Guidance Disappoints
Autodesk (ADSK) stock fell about 4% on August 28, 2026, even after the company beat Wall Street estimates in its fiscal second-quarter results. Autodesk posted $2.05 billion in revenue and $3.30 in adjusted EPS, both above expectations. Investors quickly turned their attention to the fiscal 2027 outlook. The strong Q2 numbers were not enough to…
AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial
AstraZeneca said Thursday its drug Tezspire met all primary and secondary goals in a late-stage trial. The Phase III CROSSING trial tested Tezspire against placebo in eosinophilic oesophagitis (EoE). AstraZeneca developed the drug jointly with Amgen for this chronic inflammatory oesophagus condition. What the CROSSING Trial Showed The Phase III CROSSING trial evaluated two once-every-four-week…
Nvidia Beats Q2 Targets With $96.2B Revenue, Stock Falls 1.6% on August 27
Nvidia beat Q2 earnings with $96.2B revenue and $2.22 adjusted EPS, but stock fell 1.6%. Q3 guidance of $108B signals strong AI chip demand ahead.
Bikaji Foods (BIKAJI) Shares Jump 4% to ₹635.95 After Strategic Bakery Partnership With Thayekunni Khaleel
Bikaji Foods shares jumped as much as 4% to an intraday high of ₹635.95 on August 27, 2026, before settling up 2.28% at ₹624.65. The rally followed a strategic bakery partnership with Thayekunni Khaleel, founder of the Bakemart brand, through subsidiary Bikaji Bakes Private Limited. Bikaji transferred a 30% equity stake in BBPL to Khaleel…